Difficulty: Medium
Average Score: 62%
Practice
What are examples of type I or IgE-mediated hypersensitivity reactions (select all that apply)?
Correct answer
A
Rationale
In this question, the correct answer is A) Asthma. Type I hypersensitivity reactions are mediated by IgE antibodies and involve the release of histamine and other inflammatory mediators from mast cells and basophils. Asthma is a classic example of a type I hypersensitivity reaction where the airways become inflamed and narrowed in response to triggers such as allergens.
Option B) Urticaria, option C) Angioedema, and option D) Allergic rhinitis are not examples of type I hypersensitivity reactions. Urticaria (hives) and angioedema are examples of type I immediate hypersensitivity reactions, but they are not mediated by IgE antibodies. Allergic rhinitis, although an allergic reaction, is primarily a type IV hypersensitivity reaction mediated by T cells.
Understanding the different types of hypersensitivity reactions is crucial in pharmacology as it helps healthcare professionals identify the underlying mechanisms of allergic reactions and select appropriate treatment strategies. By knowing the specific types of hypersensitivity reactions, healthcare providers can tailor interventions to target the immune pathways involved, leading to better patient outcomes.
Option B) Urticaria, option C) Angioedema, and option D) Allergic rhinitis are not examples of type I hypersensitivity reactions. Urticaria (hives) and angioedema are examples of type I immediate hypersensitivity reactions, but they are not mediated by IgE antibodies. Allergic rhinitis, although an allergic reaction, is primarily a type IV hypersensitivity reaction mediated by T cells.
Understanding the different types of hypersensitivity reactions is crucial in pharmacology as it helps healthcare professionals identify the underlying mechanisms of allergic reactions and select appropriate treatment strategies. By knowing the specific types of hypersensitivity reactions, healthcare providers can tailor interventions to target the immune pathways involved, leading to better patient outcomes.